Addus HomeCare (NASDAQ:ADUS) Given New $145.00 Price Target at Stephens

Addus HomeCare (NASDAQ:ADUS) had its target price increased by Stephens from $143.00 to $145.00 in a report released on Wednesday morning, Benzinga reports. Stephens currently has an overweight rating on the stock.

Several other research analysts have also weighed in on ADUS. TD Cowen lifted their price objective on shares of Addus HomeCare from $128.00 to $137.00 and gave the stock a “buy” rating in a research note on Thursday, August 8th. Royal Bank of Canada reduced their price target on shares of Addus HomeCare from $141.00 to $136.00 and set an “outperform” rating on the stock in a research report on Wednesday. Oppenheimer boosted their price target on shares of Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a report on Monday, September 23rd. Macquarie reaffirmed an “outperform” rating and set a $139.00 price objective on shares of Addus HomeCare in a research note on Monday. Finally, KeyCorp initiated coverage on Addus HomeCare in a research note on Friday, October 11th. They issued an “overweight” rating and a $150.00 target price for the company. One investment analyst has rated the stock with a sell rating, eight have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $131.63.

Addus HomeCare Stock Performance

Shares of Addus HomeCare stock opened at $130.96 on Wednesday. Addus HomeCare has a 52 week low of $81.51 and a 52 week high of $136.12. The stock has a market capitalization of $2.37 billion, a price-to-earnings ratio of 29.97, a PEG ratio of 2.29 and a beta of 1.04. The firm has a fifty day moving average of $129.75 and a two-hundred day moving average of $120.92.

Addus HomeCare (NASDAQ:ADUS) last released its quarterly earnings data on Monday, November 4th. The company reported $1.30 EPS for the quarter, beating analysts’ consensus estimates of $1.28 by $0.02. Addus HomeCare had a return on equity of 9.81% and a net margin of 6.18%. The business had revenue of $289.80 million during the quarter, compared to the consensus estimate of $289.42 million. During the same quarter in the prior year, the company posted $1.03 earnings per share. The firm’s revenue was up 7.1% on a year-over-year basis. As a group, research analysts forecast that Addus HomeCare will post 4.57 EPS for the current fiscal year.

Insider Activity

In related news, Director Esteban Lopez sold 500 shares of the stock in a transaction dated Wednesday, September 4th. The stock was sold at an average price of $130.03, for a total transaction of $65,015.00. Following the completion of the transaction, the director now directly owns 3,866 shares in the company, valued at approximately $502,695.98. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other Addus HomeCare news, EVP Michael D. Wattenbarger sold 21,917 shares of the business’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the sale, the executive vice president now directly owns 7,215 shares of the company’s stock, valued at $961,687.35. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Director Esteban Lopez sold 500 shares of the firm’s stock in a transaction dated Wednesday, September 4th. The shares were sold at an average price of $130.03, for a total value of $65,015.00. Following the completion of the transaction, the director now owns 3,866 shares of the company’s stock, valued at $502,695.98. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 22,917 shares of company stock worth $3,050,082 over the last three months. Corporate insiders own 4.60% of the company’s stock.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the stock. Natixis Advisors LLC increased its position in shares of Addus HomeCare by 4.8% during the 3rd quarter. Natixis Advisors LLC now owns 38,561 shares of the company’s stock worth $5,130,000 after purchasing an additional 1,777 shares during the last quarter. Empowered Funds LLC grew its stake in shares of Addus HomeCare by 25.1% in the third quarter. Empowered Funds LLC now owns 13,887 shares of the company’s stock valued at $1,847,000 after buying an additional 2,790 shares in the last quarter. Royce & Associates LP increased its holdings in Addus HomeCare by 1.2% during the third quarter. Royce & Associates LP now owns 8,924 shares of the company’s stock worth $1,187,000 after buying an additional 109 shares during the last quarter. Victory Capital Management Inc. raised its position in Addus HomeCare by 6.1% during the third quarter. Victory Capital Management Inc. now owns 84,960 shares of the company’s stock worth $11,302,000 after acquiring an additional 4,913 shares in the last quarter. Finally, Entropy Technologies LP acquired a new stake in Addus HomeCare in the third quarter valued at $226,000. 95.35% of the stock is owned by institutional investors and hedge funds.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.